Screening with 18F-fluorocholine PET/CT imaging had the best detection capability for identifying parathyroid adenoma, according to a new study.
Among 30 patients with primary hyperparathyroidism, PET/CT imaging had over a 73% detection rate of parathyroid adenoma — detecting the tumor in 22 of these patients, reported Franco Grimaldi, MD, of the University-Hospital of Udine in Italy, and colleagues. {read more here}
Researchers have developed a new technique, DeepPET, that uses deep learning to turn PET imaging data into high-quality images at a much faster rate than traditional methods. The team’s findings were detailed in a new study published in Medical Image Analysis. {read more here}
Coupling the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) with PET/CT or PET/MRI has been a boon for prostate cancer imaging. But clinicians still need to be aware of some inherent shortcomings with the radiopharmaceutical, according to a research review published online April 12 in Urology. {read more here}
18F-DCFPyL PSMA PET/CT imaging accurately localized biochemically recurrent prostate cancer and prompted clinicians to change their management plans in more than 80% of patients, according to a recent study in the Journal of Nuclear Medicine. {read more here}